Assessment of phenotypic carbapenem susceptibility and genomic epidemiology of Campylobacter from animal, food and human domains - “CarbaCamp”

Emerging evidence of carbapenem non‐susceptibility led to the EFSA recommendation to include ertapenem in the resistance monitoring of Campylobacter from 2021. The CarbaCamp project investigated carbapenem susceptibility in C. coli and C. jejuni populations from food animal surveillance contexts as well as of human origin. A total of 2,315 isolates from 16 European countries were requested, of which 1,889 were tested by disc diffusion (DD).